Bone Turnover Matters: The Raloxifene Treatment Paradox of Dramatic Decreases in Vertebral Fractures Without Commensurate Increases in Bone Density
Open Access
- 1 January 2002
- journal article
- editorial
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 17 (1), 11-14
- https://doi.org/10.1359/jbmr.2002.17.1.11
Abstract
Click on the article title to read more.This publication has 20 references indexed in Scilit:
- Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene TherapyJournal of Bone and Mineral Research, 2002
- Bone Matters: Are Density Increases Necessary to Reduce Fracture Risk?Journal of Bone and Mineral Research, 2000
- Relationship of Bone Turnover to Bone Density and FracturesJournal of Bone and Mineral Research, 1997
- In vivo reproducibility of three-dimensional structural properties of noninvasive bone biopsies using 3D-pQCTJournal of Bone and Mineral Research, 1996
- Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective studyJournal of Bone and Mineral Research, 1996
- Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacyBone, 1996
- Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal OsteoporosisNew England Journal of Medicine, 1995
- Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in minipigs. A one-year study.JCI Insight, 1995
- Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 1990
- Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.JCI Insight, 1983